Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1659 (LINC01659) is a long non-coding RNA gene that does not code for protein and is classified as a long intergenic non-coding RNA (lincRNA)[1][5]. It is listed in genomic databases, including BioGPS and Ensembl; however, there is no evidence that LINC01659 functions as a therapeutic target, nor are there published studies explicitly detailing its biological functions, involvement in human disease, therapeutic targeting, or drug interactions[1]. Like other lincRNAs, it is presumed to play roles in regulating gene expression, possibly through chromatin remodeling or interaction with RNA-binding proteins, but specific data on LINC01659 are lacking[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1659 (LINC01659).